Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1973 Sep;8(3):301-8.
doi: 10.1128/iai.8.3.301-308.1973.

Consequences of smallpox vaccination in leprosy patients

Consequences of smallpox vaccination in leprosy patients

K Saha et al. Infect Immun. 1973 Sep.

Abstract

This study illustrates the consequences of smallpox revaccination in 45 lepromatous, 28 tuberculoid, and 47 normal individuals. Results obtained with intradermal inoculations indicated that the patients with leprosy were associated with a relative anergy against the vaccinia virus, the anergy being minimal in the tuberculoid leprosy but marked in the cases with lepromatous leprosy. Major vaccinial reactions were observed more often in patients with lepromatous leprosy than in the controls or patients with tuberculoid leprosy. Furthermore in a patient with lepromatous leprosy, vaccinia necrosum also developed. The smallpox vaccination with live virus also appeared as a provocative factor for the precipitation of lepra reaction in the lepromatous leprosy cases. After 3 weeks of vaccination, the frequency of the specific humoral antibody response was the same in the tuberculoid patients and controls while it was higher in the cases with lepromatous leprosy. The prevaccination titer of total hemagglutination inhibition antibody was significantly higher in the lepromatous leprosy cases. However, the postvaccinial, humoral antibody response of the lepromatous patients was of the same magnitude as that observed in the normal individuals, and it was mainly due to a 2-mercaptoethanol-resistant antibody.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Immunochemistry. 1965 Sep;2(3):235-54 - PubMed
    1. Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):255-73 - PubMed
    1. Br Med Bull. 1967 Jan;23(1):60-5 - PubMed
    1. Clin Exp Immunol. 1968 Mar;3(3):269-76 - PubMed
    1. Bull World Health Organ. 1969;41(6):793-804 - PubMed

MeSH terms

LinkOut - more resources